Correlation Between Annexon and INmune Bio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Annexon and INmune Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Annexon and INmune Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Annexon and INmune Bio, you can compare the effects of market volatilities on Annexon and INmune Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Annexon with a short position of INmune Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Annexon and INmune Bio.

Diversification Opportunities for Annexon and INmune Bio

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Annexon and INmune is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Annexon and INmune Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on INmune Bio and Annexon is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Annexon are associated (or correlated) with INmune Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of INmune Bio has no effect on the direction of Annexon i.e., Annexon and INmune Bio go up and down completely randomly.

Pair Corralation between Annexon and INmune Bio

Given the investment horizon of 90 days Annexon is expected to under-perform the INmune Bio. But the stock apears to be less risky and, when comparing its historical volatility, Annexon is 1.17 times less risky than INmune Bio. The stock trades about -0.5 of its potential returns per unit of risk. The INmune Bio is currently generating about -0.27 of returns per unit of risk over similar time horizon. If you would invest  617.00  in INmune Bio on August 29, 2024 and sell it today you would lose (129.00) from holding INmune Bio or give up 20.91% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Annexon  vs.  INmune Bio

 Performance 
       Timeline  
Annexon 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Annexon has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
INmune Bio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days INmune Bio has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's primary indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Annexon and INmune Bio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Annexon and INmune Bio

The main advantage of trading using opposite Annexon and INmune Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Annexon position performs unexpectedly, INmune Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in INmune Bio will offset losses from the drop in INmune Bio's long position.
The idea behind Annexon and INmune Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Global Correlations
Find global opportunities by holding instruments from different markets
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios